A structured systematic review evaluates randomized trials of specific traditional Chinese medicine formulations used alongside standard care for ischemic stroke across acute, recovery, and prevention stages.
Key Takeaways
- Ischemic stroke is a leading cause of death and long-term disability
- We searched seven bibliographic databases and one clinical trial registry to 8 April 2026
- Nine RCTs enrolling 12,348 randomized participants were eligible